Delivery Order SPE2DB22D3004-SPE2DB25FQT37

Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,897.08 firm fixed-price delivery order has a period of performance through May 16, 2025 and was awarded on May 15, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $2,633.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 23, 2024. The contract has an ultimate completion date of September 24, 2024 and is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $5,437.04 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 20, 2024, with a completion date of September 23, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 held by Amerisourcebergen with the DLA...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,363.00 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 28, 2023, with a completion date of May 1, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,424.26, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 29, 2025. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant...
This federal contract award is for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,270.24 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 17, 2024. The contract has an ultimate completion date of October 18, 2024 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The contract, valued at $15,002.00, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024. The contract is a firm fixed-price delivery order with a completion date of November 15, 2024. The contract is not designated as a set-aside....
This federal contract award is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $10,417.20 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 15, 2024. The contract has an ultimate completion date of August 16, 2024 and does not use any set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,030.54, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 13, 2024. The contract is not designated as a set-aside....
This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $5,225.04 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 17, 2023. The contract has a completion date of February 21, 2023 and was not designated with any set-aside requirements. Amerisourcebergen maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FQT37
    Delivery Order

This federal contract award is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $10,300.16 firm fixed-price delivery order contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 19, 2025, with a completion date of May 20, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for the military healthcare programs of the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 8/18/25, 9:57 AM